ACAM2000

Drug Emergent BioSolutions Inc.
Total Payments
$13,301
Transactions
15
Doctors
14
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $12,301 14 13
2019 $1,000 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $12,301 14 92.5%
Consulting Fee $1,000 1 7.5%

Payments by Type

Research
$12,301
14 transactions
General
$1,000
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
VGIV Emergent BioSolutions Inc. $12,301 13

Top Doctors Receiving Payments for ACAM2000

Doctor Specialty Location Total Records
, MD Anatomic Pathology & Clinical Pathology Shreveport, LA $1,726 2
, MD Cardiovascular Disease Atlanta, GA $1,000 1
, D.O Family Medicine Orlando, FL $950.00 1
Colleen Hunsaker Scottsdale, AZ $875.00 1
, MD Family Medicine College Station, TX $875.00 1
, M.D Family Medicine Wichita Falls, TX $875.00 1
, M.D Family Medicine Yuma, AZ $875.00 1
, MD Internal Medicine Jacksonville, FL $875.00 1
Gabriel Sanchez Tampa, FL $875.00 1
, M.D Anatomic Pathology & Clinical Pathology Bowling Green, KY $875.00 1
, MD Internal Medicine Wilmington, NC $875.00 1
, M.D Family Medicine Lubbock, TX $875.00 1
, MD Anatomic Pathology & Clinical Pathology Lackland, TX $875.00 1
, M.D Family Medicine Albuquerque, NM $875.00 1

About ACAM2000

ACAM2000 is a drug associated with $13,301 in payments to 14 healthcare providers, recorded across 15 transactions in the CMS Open Payments database. The primary manufacturer is Emergent BioSolutions Inc..

Payment data is available from 2019 to 2020. In 2020, $12,301 was paid across 14 transactions to 13 doctors.

The most common payment nature for ACAM2000 is "Unspecified" ($12,301, 92.5% of total).

ACAM2000 is associated with 1 research study, including "VGIV" ($12,301).